Tetrahydropyridopyrimidine pan-kras inhibitors
US-2026035389-A1 · Feb 5, 2026 · US
This page is not indexed by search engines while we improve data quality.
Ivetac Anthony patents
Ivetac Anthony is listed as an inventor on 31 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ivetac Anthony |
| Total patents | 31 |
| First publication | May 26, 2015 |
| Latest publication | Feb 5, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Salts of sos1 inhibitors
US-2025382290-A1 · Dec 18, 2025 · US
Tetrahydropyridopyrimidine pan-kras inhibitors
US-2025368649-A1 · Dec 4, 2025 · US
Tetrahydropyridopyrimidine pan-KRas inhibitors
US-12421253-B2 · Sep 23, 2025 · US
Sos1 inhibitors
US-2025270220-A1 · Aug 28, 2025 · US
SOS1 inhibitors
US-12304915-B2 · May 20, 2025 · US
Sos1 inhibitors
US-2025059182-A1 · Feb 20, 2025 · US
Tetrahydropyridopyrimidine pan-kras inhibitors
US-2024376127-A1 · Nov 14, 2024 · US
Aminopyridine-based MTA-Cooperative PRMT5 Inhibitors
US-2024368153-A1 · Nov 7, 2024 · US
MTA-Cooperative PRMT5 Inhibitors
US-2024208912-A1 · Jun 27, 2024 · US
Recent patents
Latest publications not already listed above.
Tetrahydropyridopyrimidine pan-KRas inhibitors
US-11999753-B2 · Jun 4, 2024 · US
QUINAZOLINE PAN-KRas INHIBITORS
US-2024025907-A1 · Jan 25, 2024 · US
Sos1 inhibitors
US-2023312482-A1 · Oct 5, 2023 · US
SOS1 inhibitors
US-11702418-B2 · Jul 18, 2023 · US
Sos1 inhibitors
US-2023137886-A1 · May 4, 2023 · US
MTA-Cooperative PRMT5 Inhibitors
US-2023054883-A1 · Feb 23, 2023 · US
MTA-cooperative PRMT5 inhibitors
US-11492351-B2 · Nov 8, 2022 · US
MTA-cooperative PRMT5 inhibitors
US-11479551-B2 · Oct 25, 2022 · US
Tetrahydropyridopyrimidine pan-kras inhibitors
US-2022194961-A1 · Jun 23, 2022 · US
Sos1 inhibitors
US-2021188857-A1 · Jun 24, 2021 · US
MTA-Cooperative PRMT5 Inhibitors
US-2021079003-A1 · Mar 18, 2021 · US
MTA-Cooperative PRMT5 Inhibitors
US-2021078994-A1 · Mar 18, 2021 · US
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
US-10407409-B2 · Sep 10, 2019 · US
6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
US-2018186772-A1 · Jul 5, 2018 · US
6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD
US-9944626-B2 · Apr 17, 2018 · US
6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
US-2017275271-A1 · Sep 28, 2017 · US
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
US-9708296-B2 · Jul 18, 2017 · US
6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
US-2016251337-A1 · Sep 1, 2016 · US
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
US-9345713-B2 · May 24, 2016 · US
6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
US-2015224113-A1 · Aug 13, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Mirati Therapeutics Inc | 22 |
| Takeda Pharmaceuticals Co | 4 |
| Takeda Pharmaceutical | 3 |
| Takeda Pharmaceuticals Co | 2 |
| Brown Jason W | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D487/04 | 23 |
| C07D401/04 | 21 |
| A61K31/5377 | 21 |
| A61P35/00 | 21 |
| C07D471/04 | 20 |